[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 748,343
  • Shares Outstanding, K 83,895
  • Annual Sales, $ 77,270 K
  • Annual Income, $ -79,000 K
  • EBIT $ -74 M
  • EBITDA $ -64 M
  • 60-Month Beta 0.96
  • Price/Sales 9.26
  • Price/Cash Flow N/A
  • Price/Book 8.61

Options Overview Details

View History
  • Implied Volatility 71.49% (-3.42%)
  • Historical Volatility 89.92%
  • IV Percentile 4%
  • IV Rank 3.75%
  • IV High 442.01% on 10/22/25
  • IV Low 57.03% on 09/04/25
  • Expected Move (DTE 21) 0.68 (8.35%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 108
  • Volume Avg (30-Day) 150
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 14,484
  • Open Int (30-Day) 13,341
  • Expected Range 7.46 to 8.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.13
  • Number of Estimates 1
  • High Estimate $-0.13
  • Low Estimate $-0.13
  • Prior Year $-0.30
  • Growth Rate Est. (year over year) +56.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.50 +48.00%
on 07/29/26
8.98 -9.35%
on 08/27/26
+2.57 (+46.14%)
since 07/28/26
3-Month
4.70 +73.19%
on 06/04/26
8.98 -9.35%
on 08/27/26
+3.06 (+60.24%)
since 05/28/26
52-Week
3.10 +162.58%
on 09/12/25
8.98 -9.35%
on 08/27/26
+4.83 (+145.92%)
since 08/28/25

Most Recent Stories

More News
When Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals

Canada Goose, Capital Clean Energy Carriers and SOPHiA Genetics have each seen unusual trading volume recently, driven by tariffs, LNG demand, and a strong earnings beat, respectively.

CCEC : 22.72 (-0.26%)
SOPH : 8.14 (-8.74%)
GOOS : 8.24 (+1.73%)
SOPHiA GENETICS Reports Second Quarter 2026 Results

BOSTON and ROLLE, Switzerland , Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the second quarter...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

BOSTON and ROLLE, Switzerland , Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS  (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics...

SOPH : 8.14 (-8.74%)
AZN : 162.70 (-1.11%)
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026

BOSTON and ROLLE, Switzerland , July 21, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today announced it will release its financial results...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting

Shareholders adopt all proposals, co-founder Dr. Jurgi Camblong elected as Executive Chairman of the Board, Ross Muken elected as new member of the Board ahead of his appointment as CEO effective July...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares

BOSTON and ROLLE, Switzerland , June 19, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares

BOSTON and ROLLE, Switzerland , June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares

BOSTON and ROLLE, Switzerland , June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwritten...

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting

Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board

SOPH : 8.14 (-8.74%)
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center

SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology

SOPH : 8.14 (-8.74%)

Business Summary

SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights...

See More

Key Turning Points

3rd Resistance Point 9.53
2nd Resistance Point 9.22
1st Resistance Point 8.68
Last Price 8.14
1st Support Level 7.83
2nd Support Level 7.52
3rd Support Level 6.98

See More

52-Week High 8.98
Last Price 8.14
Fibonacci 61.8% 6.73
Fibonacci 50% 6.04
Fibonacci 38.2% 5.35
52-Week Low 3.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.